AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS

Detalhes bibliográficos
Autor(a) principal: Wouk, Jéssica
Data de Publicação: 2017
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações do UNICENTRO
Texto Completo: http://tede.unicentro.br:8080/jspui/handle/jspui/694
Resumo: Introduction: Alzheimer’s disease (AD) reaches 30 million people around the world. By the limited usage of the existent drugs to treat AD, that only relive the symptoms of it, several authors report the necessity of developing new compounds that are able to act in the early stages of AD, delaying it or, avoiding its appearance. Objective: Because of that, this study aims to analyze the prophylactic effect of a natural compound, (1-6)-β-D-glucan, lasiodiplodana, over an animal model of a chronic neuroinflammation. Methodology: 84 male wistar rats were allocated in 7 groups, being one receiving no treatment (CT) and the other receiving: saline (LPS-SAL and SAL-SAL) or 05, 10 and 15 mg/kg of lasiodiplodana (LPS-05mg, LPS-10mg, LPS-15mg and SAL-15mg). After 30 days of treatment, the animals received hippocamp injections of lipopolysaccharide – LPS (LPS-SAL, LPS-05mg, LPS-10mg and LPS-15mg) or saline (SAL-SAL e SAL-15mg). CT group did not pass through any surgical intervention. The locomotor/ exploratory and emotional activities were analyzed in open field and elevated plus mazes, respectively. In order to evaluate the memory of the animals, three tools were utilized: the open field maze with object recognition task, Morris water maze and the radial maze. After the behavioral tests, euthanasia was made and the brain of the rats were taken to later analyses of TBARs (thiobarbituric acid reactive substance) and nitrate/nitrite. Results: No significant difference was found in behavioral control tests among groups. In Morris water maze task, no group demonstrated significant results, but LPS-05mg group had a tendency to be different from LPS-SAL group. In the object recognition test no group showed significant results, however, LPS-10mg group had a tendency to be different from LPS-SAL group. The protocol utilized in radial maze was not efficient in evaluating the memory deficit of the rats from present study. In the analyses of TBARs and nitrate/nitrite the only group that was significantly (P<0.01) different from LPS-SAL was the one treated with 10 mg/kg of lasiodiplodana (LPS-10mg). Conclusion: It was concluded that the treatments with 05 mg/kg and 10mg/kg of lasiodiplodana were able to revert the memory deficit caused by the neuroinflammatory model, concerning associative and non-associative memories respectively, and the dosage of 10 mg/kg was capable of relieving the oxidative stress condition triggered by neuroinflammation.
id UCEN_bcde311fb14f63507f7adc42087bc5a2
oai_identifier_str oai:localhost:jspui/694
network_acronym_str UCEN
network_name_str Biblioteca Digital de Teses e Dissertações do UNICENTRO
repository_id_str
spelling MALFATTI, CARLOS RICARDO MANECKhttp://lattes.cnpq.br/7879558601666787083.400.019-90http://lattes.cnpq.br/2064779426980952Wouk, Jéssica2017-06-13T13:10:22Z2017-02-24Wouk, Jéssica. AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS. 2017. 62 f. Dissertação (Programa de Pós-Graduação em Ciências Farmacêuticas - Mestrado / Associação Ampla com UEPG) - Universidade Estadual do Centro-Oeste, Guarapuava - PR.http://tede.unicentro.br:8080/jspui/handle/jspui/694Introduction: Alzheimer’s disease (AD) reaches 30 million people around the world. By the limited usage of the existent drugs to treat AD, that only relive the symptoms of it, several authors report the necessity of developing new compounds that are able to act in the early stages of AD, delaying it or, avoiding its appearance. Objective: Because of that, this study aims to analyze the prophylactic effect of a natural compound, (1-6)-β-D-glucan, lasiodiplodana, over an animal model of a chronic neuroinflammation. Methodology: 84 male wistar rats were allocated in 7 groups, being one receiving no treatment (CT) and the other receiving: saline (LPS-SAL and SAL-SAL) or 05, 10 and 15 mg/kg of lasiodiplodana (LPS-05mg, LPS-10mg, LPS-15mg and SAL-15mg). After 30 days of treatment, the animals received hippocamp injections of lipopolysaccharide – LPS (LPS-SAL, LPS-05mg, LPS-10mg and LPS-15mg) or saline (SAL-SAL e SAL-15mg). CT group did not pass through any surgical intervention. The locomotor/ exploratory and emotional activities were analyzed in open field and elevated plus mazes, respectively. In order to evaluate the memory of the animals, three tools were utilized: the open field maze with object recognition task, Morris water maze and the radial maze. After the behavioral tests, euthanasia was made and the brain of the rats were taken to later analyses of TBARs (thiobarbituric acid reactive substance) and nitrate/nitrite. Results: No significant difference was found in behavioral control tests among groups. In Morris water maze task, no group demonstrated significant results, but LPS-05mg group had a tendency to be different from LPS-SAL group. In the object recognition test no group showed significant results, however, LPS-10mg group had a tendency to be different from LPS-SAL group. The protocol utilized in radial maze was not efficient in evaluating the memory deficit of the rats from present study. In the analyses of TBARs and nitrate/nitrite the only group that was significantly (P<0.01) different from LPS-SAL was the one treated with 10 mg/kg of lasiodiplodana (LPS-10mg). Conclusion: It was concluded that the treatments with 05 mg/kg and 10mg/kg of lasiodiplodana were able to revert the memory deficit caused by the neuroinflammatory model, concerning associative and non-associative memories respectively, and the dosage of 10 mg/kg was capable of relieving the oxidative stress condition triggered by neuroinflammation.Introdução: A doença de Alzheimer (DA) acomete atualmente certa de 30 milhões de pessoas ao redor do mundo. Pelo uso limitado dos medicamentos existentes usados para amenizar os sintomas da doença já instalada, muitos autores relatam a necessidade do desenvolvimento de novos fármacos que atuem no estágio inicial da DA, retardando-a ou, evitando o seu aparecimento. Objetivo: Por isso o presente estudo teve como objetivo analisar in vivo o efeito profilático de um composto natural e de fácil bioprodução, a (1-6-β-D-glucana) lasiodiplodana, frente a um modelo animal de neuroinflamação crônica. Metodologia: 84 ratos wistar machos foram inicialmente alocados em 7 grupos, sendo um sem tratamento (CT) e os demais tratados com: salina ( LPS-SAL e SAL-SAL) ou 05, 10 e 15 mg/kg de lasiodiplodana (LPS-05mg, LPS-10mg, LPS-15mg, SAL-15mg). Após 30 dias de tratamento, os animais receberam injeção intra hipocampal de lipopolissacarídeo – LPS (LPS-SAL, LPS-05mg, LPS-10mg, LPS-15mg) ou salina (SAL-SAL e SAL-15mg). Os animais do grupo CT não sofreram intervenção cirúrgica. Para avaliar as atividades locomotora/exploratória e emocional dos ratos foram utilizados os labirintos de campo aberto e de cruz elevado, respectivamente. Para avaliação de memória foram utilizados: o labirinto de campo aberto utilizando a tarefa de reconhecimento de objeto, o labirinto aquático de Morris e o labirinto octogonal. Após avaliação comportamental, os animais foram eutanasiados e seus encéfalos foram retirados para análises de TBARS (espécies reativas ao ácido tiobarbitúrico) e nitrato/ nitrito. Resultados: Nenhuma diferença significativa foi encontrada nas tarefas de controle comportamental entre os grupos. Na avaliação de memória no labirinto aquático de Morris nenhum grupo tratado obteve resultado estatisticamente significativo, porém houve uma tendência do grupo LPS-05mg em ser diferente do grupo LPS-SAL. Na tarefa de reconhecimento de objetos nenhum grupo tratado demonstrou resultados significativos, porém, houve uma tendência do grupo LPS-10mg em ser diferente do grupo LPS-SAL. O protocolo utilizado no labirinto octogonal não foi eficaz para avaliar a memória dos ratos do presente estudo. Nas dosagens de TBARs e nitrato/nitrito o único grupo que mostrou-se significativamente diferente (P<0,01) do grupo LPS-SAL foi o LPS-10mg. Conclusão: Conclui-se que a dose de 5 mg/kg e 10 mg/kg de lasiodiplodana pode ser capaz de reverter o quadro amnésico subsequente ao processo neuroinflamatório, no se que diz respeito a memória associativa e não associativa, respectivamente, e a dose de 10 mg/kg é capaz de amenizar o quadro de estresse oxidativo ocasionado pela neuroinflamação.Submitted by Fabiano Jucá (fjuca@unicentro.br) on 2017-06-13T13:10:22Z No. of bitstreams: 1 Jéssica Wouk.pdf: 1894257 bytes, checksum: 83a39242573bfff769aae35f7acdc645 (MD5)Made available in DSpace on 2017-06-13T13:10:22Z (GMT). No. of bitstreams: 1 Jéssica Wouk.pdf: 1894257 bytes, checksum: 83a39242573bfff769aae35f7acdc645 (MD5) Previous issue date: 2017-02-24Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESapplication/pdfhttp://tede.unicentro.br:8080/jspui/retrieve/2132/J%c3%a9ssica%20Wouk.pdf.jpgporUniversidade Estadual do Centro-OestePrograma de Pós-Graduação em Ciências Farmacêuticas (Mestrado / Associação Ampla com UEPG)UNICENTROBrasilUnicentro::Departamento de Farmácianeuroinflamaçãoestresse oxidativocomportamentolasiodiplodananeuroinflammationoxidative stressbehaviorlasiodiplodanaCIENCIAS DA SAUDE::FARMACIAAVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOSinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis-7679163762264962259600600600600-693476683800971729069976364134497549962075167498588264571info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações do UNICENTROinstname:Universidade Estadual do Centro-Oeste (UNICENTRO)instacron:UNICENTROLICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://localhost:8080/tede/bitstream/jspui/694/1/license.txtbd3efa91386c1718a7f26a329fdcb468MD51ORIGINALJéssica Wouk.pdfJéssica Wouk.pdfapplication/pdf1894257http://localhost:8080/tede/bitstream/jspui/694/2/J%C3%A9ssica+Wouk.pdf83a39242573bfff769aae35f7acdc645MD52TEXTJéssica Wouk.pdf.txtJéssica Wouk.pdf.txttext/plain153798http://localhost:8080/tede/bitstream/jspui/694/3/J%C3%A9ssica+Wouk.pdf.txt7ac0108ebac23a0564beb8831a62b679MD53THUMBNAILJéssica Wouk.pdf.jpgJéssica Wouk.pdf.jpgimage/jpeg2643http://localhost:8080/tede/bitstream/jspui/694/4/J%C3%A9ssica+Wouk.pdf.jpgd68819cd6b3a789629056e1bcfa62687MD54jspui/6942021-05-28 00:48:19.414oai:localhost:jspui/694Tk9UQTogQ09MT1FVRSBBUVVJIEEgU1VBIFBSw5NQUklBIExJQ0VOw4dBCkVzdGEgbGljZW7Dp2EgZGUgZXhlbXBsbyDDqSBmb3JuZWNpZGEgYXBlbmFzIHBhcmEgZmlucyBpbmZvcm1hdGl2b3MuCgpMSUNFTsOHQSBERSBESVNUUklCVUnDh8ODTyBOw4NPLUVYQ0xVU0lWQQoKQ29tIGEgYXByZXNlbnRhw6fDo28gZGVzdGEgbGljZW7Dp2EsIHZvY8OqIChvIGF1dG9yIChlcykgb3UgbyB0aXR1bGFyIGRvcyBkaXJlaXRvcyBkZSBhdXRvcikgY29uY2VkZSDDoCBVbml2ZXJzaWRhZGUgClhYWCAoU2lnbGEgZGEgVW5pdmVyc2lkYWRlKSBvIGRpcmVpdG8gbsOjby1leGNsdXNpdm8gZGUgcmVwcm9kdXppciwgIHRyYWR1emlyIChjb25mb3JtZSBkZWZpbmlkbyBhYmFpeG8pLCBlL291IApkaXN0cmlidWlyIGEgc3VhIHRlc2Ugb3UgZGlzc2VydGHDp8OjbyAoaW5jbHVpbmRvIG8gcmVzdW1vKSBwb3IgdG9kbyBvIG11bmRvIG5vIGZvcm1hdG8gaW1wcmVzc28gZSBlbGV0csO0bmljbyBlIAplbSBxdWFscXVlciBtZWlvLCBpbmNsdWluZG8gb3MgZm9ybWF0b3Mgw6F1ZGlvIG91IHbDrWRlby4KClZvY8OqIGNvbmNvcmRhIHF1ZSBhIFNpZ2xhIGRlIFVuaXZlcnNpZGFkZSBwb2RlLCBzZW0gYWx0ZXJhciBvIGNvbnRlw7pkbywgdHJhbnNwb3IgYSBzdWEgdGVzZSBvdSBkaXNzZXJ0YcOnw6NvIApwYXJhIHF1YWxxdWVyIG1laW8gb3UgZm9ybWF0byBwYXJhIGZpbnMgZGUgcHJlc2VydmHDp8Ojby4KClZvY8OqIHRhbWLDqW0gY29uY29yZGEgcXVlIGEgU2lnbGEgZGUgVW5pdmVyc2lkYWRlIHBvZGUgbWFudGVyIG1haXMgZGUgdW1hIGPDs3BpYSBhIHN1YSB0ZXNlIG91IApkaXNzZXJ0YcOnw6NvIHBhcmEgZmlucyBkZSBzZWd1cmFuw6dhLCBiYWNrLXVwIGUgcHJlc2VydmHDp8Ojby4KClZvY8OqIGRlY2xhcmEgcXVlIGEgc3VhIHRlc2Ugb3UgZGlzc2VydGHDp8OjbyDDqSBvcmlnaW5hbCBlIHF1ZSB2b2PDqiB0ZW0gbyBwb2RlciBkZSBjb25jZWRlciBvcyBkaXJlaXRvcyBjb250aWRvcyAKbmVzdGEgbGljZW7Dp2EuIFZvY8OqIHRhbWLDqW0gZGVjbGFyYSBxdWUgbyBkZXDDs3NpdG8gZGEgc3VhIHRlc2Ugb3UgZGlzc2VydGHDp8OjbyBuw6NvLCBxdWUgc2VqYSBkZSBzZXUgCmNvbmhlY2ltZW50bywgaW5mcmluZ2UgZGlyZWl0b3MgYXV0b3JhaXMgZGUgbmluZ3XDqW0uCgpDYXNvIGEgc3VhIHRlc2Ugb3UgZGlzc2VydGHDp8OjbyBjb250ZW5oYSBtYXRlcmlhbCBxdWUgdm9jw6ogbsOjbyBwb3NzdWkgYSB0aXR1bGFyaWRhZGUgZG9zIGRpcmVpdG9zIGF1dG9yYWlzLCB2b2PDqiAKZGVjbGFyYSBxdWUgb2J0ZXZlIGEgcGVybWlzc8OjbyBpcnJlc3RyaXRhIGRvIGRldGVudG9yIGRvcyBkaXJlaXRvcyBhdXRvcmFpcyBwYXJhIGNvbmNlZGVyIMOgIFNpZ2xhIGRlIFVuaXZlcnNpZGFkZSAKb3MgZGlyZWl0b3MgYXByZXNlbnRhZG9zIG5lc3RhIGxpY2Vuw6dhLCBlIHF1ZSBlc3NlIG1hdGVyaWFsIGRlIHByb3ByaWVkYWRlIGRlIHRlcmNlaXJvcyBlc3TDoSBjbGFyYW1lbnRlIAppZGVudGlmaWNhZG8gZSByZWNvbmhlY2lkbyBubyB0ZXh0byBvdSBubyBjb250ZcO6ZG8gZGEgdGVzZSBvdSBkaXNzZXJ0YcOnw6NvIG9yYSBkZXBvc2l0YWRhLgoKQ0FTTyBBIFRFU0UgT1UgRElTU0VSVEHDh8ODTyBPUkEgREVQT1NJVEFEQSBURU5IQSBTSURPIFJFU1VMVEFETyBERSBVTSBQQVRST0PDjU5JTyBPVSAKQVBPSU8gREUgVU1BIEFHw4pOQ0lBIERFIEZPTUVOVE8gT1UgT1VUUk8gT1JHQU5JU01PIFFVRSBOw4NPIFNFSkEgQSBTSUdMQSBERSAKVU5JVkVSU0lEQURFLCBWT0PDiiBERUNMQVJBIFFVRSBSRVNQRUlUT1UgVE9ET1MgRSBRVUFJU1FVRVIgRElSRUlUT1MgREUgUkVWSVPDg08gQ09NTyAKVEFNQsOJTSBBUyBERU1BSVMgT0JSSUdBw4fDlUVTIEVYSUdJREFTIFBPUiBDT05UUkFUTyBPVSBBQ09SRE8uCgpBIFNpZ2xhIGRlIFVuaXZlcnNpZGFkZSBzZSBjb21wcm9tZXRlIGEgaWRlbnRpZmljYXIgY2xhcmFtZW50ZSBvIHNldSBub21lIChzKSBvdSBvKHMpIG5vbWUocykgZG8ocykgCmRldGVudG9yKGVzKSBkb3MgZGlyZWl0b3MgYXV0b3JhaXMgZGEgdGVzZSBvdSBkaXNzZXJ0YcOnw6NvLCBlIG7Do28gZmFyw6EgcXVhbHF1ZXIgYWx0ZXJhw6fDo28sIGFsw6ltIGRhcXVlbGFzIApjb25jZWRpZGFzIHBvciBlc3RhIGxpY2Vuw6dhLgo=Biblioteca Digital de Teses e Dissertaçõeshttp://tede.unicentro.br:8080/jspui/PUBhttp://tede.unicentro.br/tde_oai/oai3.phprepositorio@unicentro.br||fabianoqueiroz@yahoo.com.bropendoar:2021-05-28T03:48:19Biblioteca Digital de Teses e Dissertações do UNICENTRO - Universidade Estadual do Centro-Oeste (UNICENTRO)false
dc.title.por.fl_str_mv AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS
title AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS
spellingShingle AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS
Wouk, Jéssica
neuroinflamação
estresse oxidativo
comportamento
lasiodiplodana
neuroinflammation
oxidative stress
behavior
lasiodiplodana
CIENCIAS DA SAUDE::FARMACIA
title_short AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS
title_full AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS
title_fullStr AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS
title_full_unstemmed AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS
title_sort AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS
author Wouk, Jéssica
author_facet Wouk, Jéssica
author_role author
dc.contributor.advisor1.fl_str_mv MALFATTI, CARLOS RICARDO MANECK
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/7879558601666787
dc.contributor.authorID.fl_str_mv 083.400.019-90
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/2064779426980952
dc.contributor.author.fl_str_mv Wouk, Jéssica
contributor_str_mv MALFATTI, CARLOS RICARDO MANECK
dc.subject.por.fl_str_mv neuroinflamação
estresse oxidativo
comportamento
lasiodiplodana
topic neuroinflamação
estresse oxidativo
comportamento
lasiodiplodana
neuroinflammation
oxidative stress
behavior
lasiodiplodana
CIENCIAS DA SAUDE::FARMACIA
dc.subject.eng.fl_str_mv neuroinflammation
oxidative stress
behavior
lasiodiplodana
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::FARMACIA
description Introduction: Alzheimer’s disease (AD) reaches 30 million people around the world. By the limited usage of the existent drugs to treat AD, that only relive the symptoms of it, several authors report the necessity of developing new compounds that are able to act in the early stages of AD, delaying it or, avoiding its appearance. Objective: Because of that, this study aims to analyze the prophylactic effect of a natural compound, (1-6)-β-D-glucan, lasiodiplodana, over an animal model of a chronic neuroinflammation. Methodology: 84 male wistar rats were allocated in 7 groups, being one receiving no treatment (CT) and the other receiving: saline (LPS-SAL and SAL-SAL) or 05, 10 and 15 mg/kg of lasiodiplodana (LPS-05mg, LPS-10mg, LPS-15mg and SAL-15mg). After 30 days of treatment, the animals received hippocamp injections of lipopolysaccharide – LPS (LPS-SAL, LPS-05mg, LPS-10mg and LPS-15mg) or saline (SAL-SAL e SAL-15mg). CT group did not pass through any surgical intervention. The locomotor/ exploratory and emotional activities were analyzed in open field and elevated plus mazes, respectively. In order to evaluate the memory of the animals, three tools were utilized: the open field maze with object recognition task, Morris water maze and the radial maze. After the behavioral tests, euthanasia was made and the brain of the rats were taken to later analyses of TBARs (thiobarbituric acid reactive substance) and nitrate/nitrite. Results: No significant difference was found in behavioral control tests among groups. In Morris water maze task, no group demonstrated significant results, but LPS-05mg group had a tendency to be different from LPS-SAL group. In the object recognition test no group showed significant results, however, LPS-10mg group had a tendency to be different from LPS-SAL group. The protocol utilized in radial maze was not efficient in evaluating the memory deficit of the rats from present study. In the analyses of TBARs and nitrate/nitrite the only group that was significantly (P<0.01) different from LPS-SAL was the one treated with 10 mg/kg of lasiodiplodana (LPS-10mg). Conclusion: It was concluded that the treatments with 05 mg/kg and 10mg/kg of lasiodiplodana were able to revert the memory deficit caused by the neuroinflammatory model, concerning associative and non-associative memories respectively, and the dosage of 10 mg/kg was capable of relieving the oxidative stress condition triggered by neuroinflammation.
publishDate 2017
dc.date.accessioned.fl_str_mv 2017-06-13T13:10:22Z
dc.date.issued.fl_str_mv 2017-02-24
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv Wouk, Jéssica. AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS. 2017. 62 f. Dissertação (Programa de Pós-Graduação em Ciências Farmacêuticas - Mestrado / Associação Ampla com UEPG) - Universidade Estadual do Centro-Oeste, Guarapuava - PR.
dc.identifier.uri.fl_str_mv http://tede.unicentro.br:8080/jspui/handle/jspui/694
identifier_str_mv Wouk, Jéssica. AVALIAÇÃO DO EFEITO PROFILÁTICO DA β-GLUCANA LASIODIPLODANA SOBRE MODELO DE NEUROINFLAMAÇÃO, DÉFICIT COGNITIVO E ESTRESSE OXIDATIVO EM RATOS. 2017. 62 f. Dissertação (Programa de Pós-Graduação em Ciências Farmacêuticas - Mestrado / Associação Ampla com UEPG) - Universidade Estadual do Centro-Oeste, Guarapuava - PR.
url http://tede.unicentro.br:8080/jspui/handle/jspui/694
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv -7679163762264962259
dc.relation.confidence.fl_str_mv 600
600
600
600
dc.relation.department.fl_str_mv -6934766838009717290
dc.relation.cnpq.fl_str_mv 6997636413449754996
dc.relation.sponsorship.fl_str_mv 2075167498588264571
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Estadual do Centro-Oeste
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências Farmacêuticas (Mestrado / Associação Ampla com UEPG)
dc.publisher.initials.fl_str_mv UNICENTRO
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Unicentro::Departamento de Farmácia
publisher.none.fl_str_mv Universidade Estadual do Centro-Oeste
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações do UNICENTRO
instname:Universidade Estadual do Centro-Oeste (UNICENTRO)
instacron:UNICENTRO
instname_str Universidade Estadual do Centro-Oeste (UNICENTRO)
instacron_str UNICENTRO
institution UNICENTRO
reponame_str Biblioteca Digital de Teses e Dissertações do UNICENTRO
collection Biblioteca Digital de Teses e Dissertações do UNICENTRO
bitstream.url.fl_str_mv http://localhost:8080/tede/bitstream/jspui/694/1/license.txt
http://localhost:8080/tede/bitstream/jspui/694/2/J%C3%A9ssica+Wouk.pdf
http://localhost:8080/tede/bitstream/jspui/694/3/J%C3%A9ssica+Wouk.pdf.txt
http://localhost:8080/tede/bitstream/jspui/694/4/J%C3%A9ssica+Wouk.pdf.jpg
bitstream.checksum.fl_str_mv bd3efa91386c1718a7f26a329fdcb468
83a39242573bfff769aae35f7acdc645
7ac0108ebac23a0564beb8831a62b679
d68819cd6b3a789629056e1bcfa62687
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações do UNICENTRO - Universidade Estadual do Centro-Oeste (UNICENTRO)
repository.mail.fl_str_mv repositorio@unicentro.br||fabianoqueiroz@yahoo.com.br
_version_ 1801859368519467008